Clinical trial
Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy at the CHU, Lille: Biological Prospective Collection and Storage
NCT07609485 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Identifying Cellular and Molecular Determinants of Efficacy and Resistance in Patients Undergoing CAR-T Therapy at the CHU, Lille: Biological Prospective Collection and Storage
- Lead sponsor
- University Hospital, Lille
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- February 18, 2021
- Completion date
- February 18, 2028
- Enrollment
- 700 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, hematologic malignancy